vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Barnes & Noble Education, Inc. (BNED). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $598.2M, roughly 1.6× Barnes & Noble Education, Inc.). APTARGROUP, INC. runs the higher net margin — 7.7% vs 4.2%, a 3.5% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 6.9%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $61.9M). Over the past eight quarters, Barnes & Noble Education, Inc.'s revenue compounded faster (20.0% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

ATR vs BNED — Head-to-Head

Bigger by revenue
ATR
ATR
1.6× larger
ATR
$962.7M
$598.2M
BNED
Growing faster (revenue YoY)
ATR
ATR
+6.6% gap
ATR
13.5%
6.9%
BNED
Higher net margin
ATR
ATR
3.5% more per $
ATR
7.7%
4.2%
BNED
More free cash flow
ATR
ATR
$35.0M more FCF
ATR
$96.9M
$61.9M
BNED
Faster 2-yr revenue CAGR
BNED
BNED
Annualised
BNED
20.0%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ATR
ATR
BNED
BNED
Revenue
$962.7M
$598.2M
Net Profit
$74.3M
$25.0M
Gross Margin
21.7%
Operating Margin
11.0%
6.8%
Net Margin
7.7%
4.2%
Revenue YoY
13.5%
6.9%
Net Profit YoY
-26.4%
-49.7%
EPS (diluted)
$1.13
$0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
BNED
BNED
Q4 25
$962.7M
$598.2M
Q3 25
$961.1M
$274.2M
Q2 25
$966.0M
$233.0M
Q1 25
$887.3M
$419.7M
Q4 24
$848.1M
$559.7M
Q3 24
$909.3M
$250.9M
Q2 24
$910.1M
$192.7M
Q1 24
$915.4M
$415.4M
Net Profit
ATR
ATR
BNED
BNED
Q4 25
$74.3M
$25.0M
Q3 25
$127.9M
$-18.3M
Q2 25
$111.7M
$-23.0M
Q1 25
$78.8M
$17.9M
Q4 24
$100.9M
$43.2M
Q3 24
$100.0M
$-103.9M
Q2 24
$90.5M
$-41.9M
Q1 24
$83.1M
$-9.3M
Gross Margin
ATR
ATR
BNED
BNED
Q4 25
21.7%
Q3 25
20.2%
Q2 25
30.3%
Q1 25
22.3%
Q4 24
23.0%
Q3 24
17.9%
Q2 24
28.7%
Q1 24
24.2%
Operating Margin
ATR
ATR
BNED
BNED
Q4 25
11.0%
6.8%
Q3 25
14.2%
-8.4%
Q2 25
14.9%
-4.9%
Q1 25
12.8%
4.5%
Q4 24
14.2%
8.4%
Q3 24
15.2%
-15.4%
Q2 24
13.8%
-16.3%
Q1 24
12.2%
0.4%
Net Margin
ATR
ATR
BNED
BNED
Q4 25
7.7%
4.2%
Q3 25
13.3%
-6.7%
Q2 25
11.6%
-9.9%
Q1 25
8.9%
4.3%
Q4 24
11.9%
7.7%
Q3 24
11.0%
-41.4%
Q2 24
9.9%
-21.7%
Q1 24
9.1%
-2.2%
EPS (diluted)
ATR
ATR
BNED
BNED
Q4 25
$1.13
$0.72
Q3 25
$1.92
$-0.54
Q2 25
$1.67
$2.97
Q1 25
$1.17
$0.59
Q4 24
$1.48
$1.63
Q3 24
$1.48
$-7.69
Q2 24
$1.34
$-15.68
Q1 24
$1.23
$-3.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
BNED
BNED
Cash + ST InvestmentsLiquidity on hand
$409.5M
$11.7M
Total DebtLower is stronger
$1.1B
$122.5M
Stockholders' EquityBook value
$2.7B
$283.2M
Total Assets
$5.3B
$1.1B
Debt / EquityLower = less leverage
0.43×
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
BNED
BNED
Q4 25
$409.5M
$11.7M
Q3 25
$264.8M
$7.3M
Q2 25
$169.8M
$9.1M
Q1 25
$136.8M
$9.2M
Q4 24
$226.2M
$11.6M
Q3 24
$327.9M
$8.2M
Q2 24
$223.9M
$10.5M
Q1 24
$201.1M
$8.1M
Total Debt
ATR
ATR
BNED
BNED
Q4 25
$1.1B
$122.5M
Q3 25
$546.0M
$170.0M
Q2 25
$535.1M
$103.1M
Q1 25
$561.2M
$141.2M
Q4 24
$688.1M
$177.6M
Q3 24
$822.7M
$221.9M
Q2 24
$681.5M
$196.3M
Q1 24
$680.4M
$30.2M
Stockholders' Equity
ATR
ATR
BNED
BNED
Q4 25
$2.7B
$283.2M
Q3 25
$2.8B
$256.5M
Q2 25
$2.7B
$272.2M
Q1 25
$2.5B
$292.9M
Q4 24
$2.5B
$211.4M
Q3 24
$2.5B
$149.8M
Q2 24
$2.4B
$80.4M
Q1 24
$2.3B
$121.5M
Total Assets
ATR
ATR
BNED
BNED
Q4 25
$5.3B
$1.1B
Q3 25
$5.1B
$950.8M
Q2 25
$4.9B
$790.3M
Q1 25
$4.5B
$1.1B
Q4 24
$4.4B
$1.0B
Q3 24
$4.6B
$973.2M
Q2 24
$4.5B
$909.9M
Q1 24
$4.4B
$1.2B
Debt / Equity
ATR
ATR
BNED
BNED
Q4 25
0.43×
0.43×
Q3 25
0.20×
0.66×
Q2 25
0.20×
0.38×
Q1 25
0.22×
0.48×
Q4 24
0.28×
0.84×
Q3 24
0.32×
1.48×
Q2 24
0.28×
2.44×
Q1 24
0.29×
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
BNED
BNED
Operating Cash FlowLast quarter
$183.7M
$66.2M
Free Cash FlowOCF − Capex
$96.9M
$61.9M
FCF MarginFCF / Revenue
10.1%
10.4%
Capex IntensityCapex / Revenue
9.0%
0.7%
Cash ConversionOCF / Net Profit
2.47×
2.65×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$-4.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
BNED
BNED
Q4 25
$183.7M
$66.2M
Q3 25
$177.6M
$-67.6M
Q2 25
$126.0M
$52.6M
Q1 25
$82.7M
$-41.9M
Q4 24
$178.2M
$47.4M
Q3 24
$229.3M
$-143.5M
Q2 24
$143.6M
$81.7M
Q1 24
$92.3M
$-35.8M
Free Cash Flow
ATR
ATR
BNED
BNED
Q4 25
$96.9M
$61.9M
Q3 25
$114.3M
$-71.3M
Q2 25
$62.5M
$49.5M
Q1 25
$25.9M
$-44.7M
Q4 24
$112.2M
$44.4M
Q3 24
$162.7M
$-147.5M
Q2 24
$75.4M
$79.1M
Q1 24
$16.7M
$-39.0M
FCF Margin
ATR
ATR
BNED
BNED
Q4 25
10.1%
10.4%
Q3 25
11.9%
-26.0%
Q2 25
6.5%
21.3%
Q1 25
2.9%
-10.7%
Q4 24
13.2%
7.9%
Q3 24
17.9%
-58.8%
Q2 24
8.3%
41.1%
Q1 24
1.8%
-9.4%
Capex Intensity
ATR
ATR
BNED
BNED
Q4 25
9.0%
0.7%
Q3 25
6.6%
1.4%
Q2 25
6.6%
1.3%
Q1 25
6.4%
0.7%
Q4 24
7.8%
0.5%
Q3 24
7.3%
1.6%
Q2 24
7.5%
1.4%
Q1 24
8.3%
0.8%
Cash Conversion
ATR
ATR
BNED
BNED
Q4 25
2.47×
2.65×
Q3 25
1.39×
Q2 25
1.13×
Q1 25
1.05×
-2.34×
Q4 24
1.77×
1.10×
Q3 24
2.29×
Q2 24
1.59×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

BNED
BNED

Course Materials Product$459.3M77%
General Merchandise Product$112.9M19%
Serviceand Other$26.1M4%

Related Comparisons